Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Bethany Alabek

Physician Assistant Bethel Park, PA Physician Assistant

NPI 1801149158 CMS profile 10620148

2000 Oxford Dr Ste 211, Bethel Park, PA 15102

Open in the dashboard

General payments

$15,195

847 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Bethany Alabek of Bethel Park, PA is reported in the CMS Open Payments database as having received $15,195 across 847 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,913 203
2024 General $4,963 257
2023 General $3,407 236
2021 General $2,913 151

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bethany Alabek
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Bethany Alabek were reported at $3,913. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Bethany Alabek Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $2,913 $132 $37–$438 $132
2022 $0 $155 $48–$522 $149
2023 $3,407 $167 $52–$557 $160
2024 $4,963 $178 $55–$600 $164
2025 $3,913 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Boston Scientific Corporation $4,493 253 payments
  2. Abbott Laboratories $4,435 139 payments
  3. Stryker Corporation $3,591 399 payments
  4. Medical Device Business Services, Inc. $1,351 7 payments
  5. VB Spine LLC $728 33 payments
  6. Ethicon US, LLC $326 11 payments
  7. SI-BONE, Inc. $157 1 payment
  8. Becton, Dickinson and Company $47 1 payment
  9. Nevro Corp. $34 1 payment
  10. GRT US Holding, Inc. $21 1 payment
  11. Other $12 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $14,042 844 payments
  2. Travel and Lodging $1,153 3 payments
Products named General payments · program years 2021–2025
  1. EVEREST SPINAL SYSTEM $2,511 268 payments
  2. WaveWriter Alpha Prime 16 $2,134 142 payments
  3. Proclaim IPG $1,785 53 payments
  4. PROCLAIM Neuromodulation $1,700 58 payments
  5. STRATAFIX $1,639 16 payments
  6. General - Pain Management $1,229 54 payments
  7. YUKON OCT SPINAL SYSTEM $554 52 payments
  8. MESA SPINAL SYSTEM $439 51 payments
  9. CASCADIA INTERBODY SYSTEM $436 44 payments
  10. PROCLAIM Structural Heart $412 12 payments
  11. Other $3,391 245 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

93

Median for Physician Assistant: 241

Drug cost

$400

Median for Physician Assistant: $4,110

Branded share of claims

33.3%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cephalexin Generic 42 $293
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 31 $59
Cyclobenzaprine Hcl Generic 20 $48

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 39 billing codes

Paid by Medicare

$19,158

Of which drugs: $979

Medicare patients

72

Average age 76

Services billed

587

39 women, 33 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 35%
Osteoporosis 28%
Ischemic heart disease 25%
Chronic kidney disease 25%
Diabetes 24%
Atrial fibrillation 24%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 14 170 $975

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

847 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record